CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 85 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,648,000 | -34.5% | 789,603 | -45.4% | 0.35% | -47.0% |
| Q1 2020 | $5,571,000 | +452.7% | 1,446,953 | +632.3% | 0.66% | +362.9% |
| Q1 2019 | $1,008,000 | +191.3% | 197,594 | +9.7% | 0.14% | +107.2% |
| Q4 2018 | $346,000 | -54.8% | 180,198 | -11.0% | 0.07% | -57.1% |
| Q3 2018 | $765,000 | +63.5% | 202,489 | +35.0% | 0.16% | -14.4% |
| Q2 2018 | $468,000 | +56.0% | 150,000 | +49.8% | 0.19% | +9.9% |
| Q3 2015 | $300,000 | -84.6% | 100,129 | -74.7% | 0.17% | -82.9% |
| Q2 2015 | $1,951,000 | +23.5% | 395,000 | +8.2% | 1.00% | +22.6% |
| Q1 2015 | $1,580,000 | +68.8% | 365,000 | +15.9% | 0.82% | +136.9% |
| Q4 2014 | $936,000 | – | 315,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |